Xie Jian 4

What Happened

• Jian Xie, President and Chief Operating Officer of Fulgent Genetics (FLGT), had 4,361 shares withheld to satisfy tax withholding obligations on vested restricted stock units. The shares were valued at $16.31 each for a total of $71,128. This is a tax-withholding disposition (transaction code F), a routine administrative action rather than a discretionary open-market sale.

Key Details

• Transaction date: 2026-04-26; Filing date: 2026-04-28 (filed timely).
• Price per share: $16.31; Shares withheld/disposed: 4,361; Total value: $71,128.
• Shares owned after transaction: Not disclosed in this filing.
• Footnote F1: Shares were withheld to satisfy tax obligations on RSUs assumed under the merger agreement dated Nov 7, 2022; the original awards were reported on Form 4 filed Nov 9, 2022.
• Footnote F2: Some securities are held by The Hsieh Family Dynasty Trust (dated Jan 27, 2010). Mr. Xie serves on the trust’s investment committee and disclaims beneficial ownership except for any pecuniary interest.

Context

• This was a tax-withholding (cashless) disposition tied to RSU vesting, not an intentional investment sale; such withholdings are common and typically do not indicate insider sentiment about the company’s stock.
• The filing appears timely under Form 4 rules (reported within two business days of the transaction).